*Due to inclement weather, this event will be rescheduled for Monday, January 6, 2020. We apologize for any inconvenience*
Reception: 6:00pm - 6:45pm
Presentations: 6:45pm - 7:45pm
Panel Discussion: 7:45pm - 8:00pm
The New York Academy of Medicine, 1216 Fifth Avenue at 103rd Street, New York, NY 10029
Free, but advance registration is required
The New York Academy of Medicine Section on Ophthalmology
This symposium highlights advances in the fields of artificial intelligence and machine learning in ophthalmology. Leading experts will provide an update on the progress of these new technologies in supporting high quality eye and vision care.
6:00pm – 6:45pm:
|6:45pm – 7:45pm:|
Presentations and Discussion
Welcome and Introduction
“Artificial Intelligence and its use in improving outcomes for cataract and refractive surgery”
“Artificial Intelligence, Definitions, and Applications in Ophthalmology"
“Searching for the unseen: Artificial Intelligence and the marketplace for philanthropy in global ophthalmology”
“The Brave New World of Machine Learning and Artificial Intelligence in Retina: 2019 and Beyond”
“The Artificial Intelligence Glaucoma Wishlist: Can it be realized?”
|7:45pm – 8:00pm||Panel Discussion|
Sumayya Ahmad, MD is Assistant Professor of Ophthalmology at the Icahn School of Medicine at Mount Sinai, where her clinical focus includes cataract surgery, full thickness and partial thickness corneal transplantation, laser vision correction, dry eye, corneal ulcers, and ocular surface disease. Her research interests include evaluating outcomes in ocular surface disease and the impact of diabetes on the cornea. Dr. Ahmad has authored several peer-reviewed scientific articles and has given a number of presentations on keratitis, dry eye, and the outcomes of the Boston Type 1 Keratoprosthesis.
Lama A. Al-Aswad, MD, MPH is the Director of Tele-Ophalmology, AI and Innovations at NYU Langone Health. She also serves as the Vice Chair of Innovations and a Professor Ophthalmology. Previously, she was an Associate Professor of Ophthalmology at Columbia University Medical Center and was the director of the glaucoma screening program at Columbia University and served on the Columbia BSCS committee since 2006. She has served on a multitude of other committees as well, including the Columbia University Implementation of the Academic Tracks committee, Woman in Ophthalmology committee and Glaucoma 360 Program committee. Dr. Al-Aswad is the founder and President of the Save Vision Foundation, based in New York, and initiated the mobile Free Eye exam program in 2017. Dr. Al-Aswad has received multiple awards, the most recent of which is Achievement Award from the American Academy of Ophthalmology in 2012 and the Visionary Award for Hospital Based Screening Programs from the Friends of the Congressional Caucus Foundation in 2011.
Ebby Elahi, MD, FACS is a Clinical Professor of Ophthalmology, Otolaryngology, and Public Health at the Icahn School of Medicine at Mount Sinai. He also serves as Director of Fifth Avenue Eye Associates and FACES Fifth Avenue. Dr. Elahi has also served as co-director of Mount Sinai’s Ophthalmic, Plastic, and Reconstructive Surgery Fellowship program. Dr. Elahi is a fellow of the American Academy of Ophthalmology, the American Society of Ophthalmic Plastic and Reconstructive Surgery, and the American College of Surgeons. He is the current president of the Mount Sinai Eye Alumni Association and the immediate past president of the New York Facial Plastic Surgery Society. Dr. Elahi’s extensive clinical experience ranges from surgical and non-surgical aesthetic procedures to complex conditions involving eyelids, the orbit, and the lacrimal system. His special interests lie in the correction of age-related facial, orbital, and eyelid changes, advanced surgical management of eyelid and orbital malignancies, and treatment of thyroid-related eye disease. For the past twenty years, Dr. Elahi has been an advocate for issues surrounding global health. Currently, he serves as Director of International Affairs at the Virtue Foundation, an NGO in special consultative status to the Economic and Social Council at the United Nations.
Szilárd Kiss, MD is the Chief of the Retina Service, Director of Clinical Research, Chair of the Graduate Faculty Council, and Associate Professor of Ophthalmology at Weill Cornell Medical College in New York City. Dr. Kiss's research career started as an undergraduate where, in conjunction with the National Aeronautics and Space Administration and the Department of Defense, he evaluated the implications of microgravity on early developmental patterning with scientific experiments launched on the space shuttle Discovery and the space shuttle Columbia. Currently, Dr. Kiss’s clinical and translational research efforts focus on four broad areas: ocular gene and cellular therapy, novel therapeutic targets for ocular neovascularization, complex vitreoretinal surgical techniques, and retinal imaging. Dr. Kiss has participated as a principal investigator in over three-dozen prospective clinical trials and laboratory investigations. Dr. Kiss was among a select group of retina specialists world-wide to be elected by his peers as a Charter Member of the Retina Hall of Fame.
Louis R. Pasquale, MD is Site Chair for the Departments of Ophthalmology at Mount Sinai Hospital and Mount Sinai Queens. He is also Deputy Chair for Ophthalmology Research for the Mount Sinai Healthcare System and Director of the Joint New York Eye and Eye /Mt. Sinai Eye and Vision Research Institute. Previously, he was Professor of Ophthalmology and Distinguished Scholar in Ophthalmology at Harvard Medical School. In addition to co-directing Harvard’s Glaucoma Center of Excellence, he directed the Glaucoma Service, Glaucoma Fellowship Program and the Teleretinal Program at Massachusetts Eye and Ear Infirmary. Dr. Pasquale is an editorial board member of PLOS One, Journal of Glaucoma, Ophthalmology Glaucoma, International Glaucoma Review, Asia Pacific Journal of Ophthalmology and American Journal of Ophthalmology editorial boards. He is a member of the National Institute of Health’s National Advisory Eye Council and the ARVO Glaucoma Section Trustee. Furthermore, he is a member of the American Ophthalmological Society and the Glaucoma Research Society. He is an NIH Principal Investigator with continuous support since 2006. His research, which leverages the rich resources available in the Nurses Health Study, Health Professional Follow-up Study and the Women’s Genome Health Study, focuses on the discovery of primary prevention strategies in the open-angle glaucomas. His work has highlighted environmental risk factors for exfoliation syndrome and the role nitric oxide signaling plays in the pathogenesis of primary open angle glaucoma.